Samsara BioCapital

Suggest edits

Also headquartered in Palo Alto

Companies in the same industry

Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 15

Portfolio

Portfolio Tracker

Add info

ElevateBio raises $525M to advance its cell and gene therapy technologies

$85,000,000 Venture capital (Series A)

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location

$100,000,000 Venture capital (Series A)

Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early …

$71,500,000 Venture capital (Series B)

A2 Biotherapeutics Closes $71.5M Series B Funding

$100,000,000 Undisclosed

Flame Biosciences Completes $100M Common Stock Financing

$239,000,000 Venture capital (Series D)

Recursion Raises $239M in Series D Equity Financing

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

$106,000,000 Post-IPO equity

Chinook Therapeutics Raises $106M in Funding

Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech

$93,500,000 Venture capital (Series C)

Bolt Biotherapeutics Raises $93.5M in Series C Financing

$76,000,000 Venture capital (Series B)

Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders

Autobahn Therapeutics Raises $76M in Series B Financing

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

$45,000,000 Venture capital (Series C)

Palvella Therapeutics Closes $45M Series C Financing Round

$170,000,000 Venture capital (Series B)

ElevateBio Raises $170M in Series B Financing

Cell and gene therapy startup ElevateBio raises $170 million

$100,000,000 Venture capital (Series D)

Forma Therapeutics Closes $100M Series D Financing

$113,800,000 IPO

Index

By TNW